0000000000795781

AUTHOR

Ana Belen Castello-domenech

showing 2 related works from this author

Sleep Alterations in Non-demented Older Individuals: The Role of Cortisol

2017

Background: Sleep alterations can impair quality of life and contribute to disease progression but they, and their features and contributing factors, are rarely analysed in institutionalised older individuals. In this study, we investigated sleep alterations, the factors involved, and the role of cortisol in sleep-related problems in institutionalised individuals. Methods: We conducted a descriptive cross-sectional study in participants living in nursing homes in Valencia (Spain); sleep alterations were determined based on two validated tools: the Athens insomnia scale and Oviedo sleep questionnaire. Plasma cortisol was measured in the morning and determined by high performance liquid chrom…

MaleSleep Wake DisordersAgingmedicine.medical_specialtyCortisol awakening responseHydrocortisonemedicine.drug_classEndocrinology Diabetes and MetabolismPopulation01 natural sciencesHypnotic03 medical and health sciences0302 clinical medicinemedicineInsomniaHumansImmunology and AllergyRestless legs syndrome0101 mathematicsAthens insomnia scalePsychiatryeducationAgedAged 80 and overeducation.field_of_studySleep disorderbusiness.industryMiddle Agedmedicine.diseaseCircadian Rhythm010101 applied mathematicsCross-Sectional StudiesPsychotropic drugDementiaFemalemedicine.symptomSleepbusiness030217 neurology & neurosurgeryEndocrine, Metabolic & Immune Disorders-Drug Targets
researchProduct

Frailty syndrome is associated with changes in peripheral inflammatory markers in prostate cancer patients undergoing androgen deprivation therapy.

2019

To evaluate the role of peripheral inflammation (leukocyte differential count, the proinflammatory cytokines IL-beta, TNF-α, IL-6, IL-8, and the inflammatory markers fibrinogen and C-reactive protein [CRP]) in frailty syndrome in patients with prostate cancer (CaP) undergoing antiandrogen therapy (ADT).A total of 46 men between 51 and 92 years of age with CaP and receiving ADT were classified as frail, prefrail or robust according to the Fried scale. A geriatric assessment was performed, based on the Minimental State Examination for cognitive function, the Barthel index for basic activities of daily living, the Yesavage scale for geriatric depression, and the Athens insomnia scale. In addit…

OncologyMalemedicine.medical_specialtyUrologyFrailty syndrome030232 urology & nephrologyInflammationFibrinogenSeverity of Illness IndexProinflammatory cytokineAndrogen deprivation therapy03 medical and health sciencesProstate cancer0302 clinical medicineInternal medicinemedicineHumansLymphocyte CountAthens insomnia scaleGeriatric AssessmentAgedAged 80 and overFrailtybusiness.industryProstatic NeoplasmsAndrogen AntagonistsMiddle Agedmedicine.diseaseCross-Sectional StudiesOncology030220 oncology & carcinogenesisBiomarker (medicine)medicine.symptomInflammation Mediatorsbusinessmedicine.drugUrologic oncology
researchProduct